Compile Data Set for Download or QSAR
maximum 50k data
Found 120 Enz. Inhib. hit(s) with all data for entry = 9603
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242374(US10047093, 8-31 | US10392392, Example 8-31 | US10...)
Affinity DataIC50:  1nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242397(US10047093, 8-79 | US10392392, Example 8-79 | US10...)
Affinity DataIC50:  2nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242388(US10047093, 8-68 | US10392392, Example 8-68 | US10...)
Affinity DataIC50:  4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242352(US10047093, 8-8 | US10392392, Example 8-8 | US1087...)
Affinity DataIC50:  4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242380(US10047093, 8-37 | US10392392, Example 8-37 | US10...)
Affinity DataIC50:  4nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242372(US10047093, 8-29 | US10392392, Example 8-29 | US10...)
Affinity DataIC50:  5nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043692(CHEMBL3355542 | US10047093, 8-52 | US10392392, Exa...)
Affinity DataIC50:  5nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242348(US10047093, 8-4 | US10392392, Example 8-4 | US1087...)
Affinity DataIC50:  7nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242378(US10047093, 8-35 | US10392392, Example 8-35 | US10...)
Affinity DataIC50:  7nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM228294(US10047093, 8-11 | US10392392, Example 8-11 | US10...)
Affinity DataIC50:  8nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM476631(US10875864, EX. 8-70)
Affinity DataIC50:  8nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242354(US10047093, 8-10 | US10392392, Example 8-10 | US10...)
Affinity DataIC50:  9nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242351(US10047093, 8-7 | US10392392, Example 8-7 | US1087...)
Affinity DataIC50:  10nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242390(US10047093, 8-71 | US10392392, Example 8-71 | US10...)
Affinity DataIC50:  12nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242362(US10047093, 8-19 | US10392392, Example 8-19 | US10...)
Affinity DataIC50:  13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242345(US10047093, 8-1 | US10392392, Example 8-1 | US1087...)
Affinity DataIC50:  13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242353(US10047093, 8-9 | US10392392, Example 8-9 | US1087...)
Affinity DataIC50:  13nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242395(US10047093, 8-77 | US10392392, Example 8-77 | US10...)
Affinity DataIC50:  14nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242403(US10392392, Example 8-86 | US10875864, EX. 8-86 | ...)
Affinity DataIC50:  14nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242363(US10047093, 8-20 | US10392392, Example 8-20 | US10...)
Affinity DataIC50:  16nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242387(US10047093, 8-45 | US10392392, Example 8-45 | US10...)
Affinity DataIC50:  16nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043662(CHEMBL3355552 | US10047093, 8-56 | US10392392, Exa...)
Affinity DataIC50:  17nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM476634(US10875864, EX. 8-73)
Affinity DataIC50:  17nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242346(US10047093, 8-2 | US10392392, Example 8-2 | US1087...)
Affinity DataIC50:  18nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM228328(US10047093, 8-38 | US10392392, Example 8-38 | US10...)
Affinity DataIC50:  18nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242402(US10392392, Example 8-85 | US10875864, EX. 8-85 | ...)
Affinity DataIC50:  19nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242370(US10047093, 8-27 | US10392392, Example 8-27 | US10...)
Affinity DataIC50:  23nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043697(CHEMBL3355987 | US10047093, 8-63 | US10392392, Exa...)
Affinity DataIC50:  23nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043655(CHEMBL3355557 | US10047093, 8-95 | US10392392, Exa...)
Affinity DataIC50:  24nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043655(CHEMBL3355557 | US10047093, 8-95 | US10392392, Exa...)
Affinity DataIC50:  24nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043674(CHEMBL3355550 | US10047093, 8-54 | US10392392, Exa...)
Affinity DataIC50:  25nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043690(CHEMBL3355544 | US10047093, 8-46 | US10392392, Exa...)
Affinity DataIC50:  27nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242345(US10047093, 8-1 | US10392392, Example 8-1 | US1087...)
Affinity DataIC50:  28nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM476587(US10875864, EX. 8-25)
Affinity DataIC50:  30nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242350(US10047093, 8-6 | US10392392, Example 8-6 | US1087...)
Affinity DataIC50:  30nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242347(US10047093, 8-3 | US10392392, Example 8-3 | US1087...)
Affinity DataIC50:  30nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242376(US10047093, 8-33 | US10392392, Example 8-33 | US10...)
Affinity DataIC50:  33nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM476586(US10875864, EX. 8-24)
Affinity DataIC50:  34nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242399(US10047093, 8-82 | US10392392, Example 8-82 | US10...)
Affinity DataIC50:  34nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242349(US10047093, 8-5 | US10392392, Example 8-5 | US1087...)
Affinity DataIC50:  36nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242405(US10047093, 8-92 | US10392392, Example 8-92 | US10...)
Affinity DataIC50:  38nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242365(US10047093, 8-22 | US10392392, Example 8-22 | US10...)
Affinity DataIC50:  41nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043693(CHEMBL3355541 | US10047093, 8-67 | US10392392, Exa...)
Affinity DataIC50:  45nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242364(US10047093, 8-21 | US10392392, Example 8-21 | US10...)
Affinity DataIC50:  46nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM35052(K00152 | US10047093, 8-39 | US10392392, Example 8-...)
Affinity DataIC50:  48nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242398(US10047093, 8-80 | US10392392, Example 8-80 | US10...)
Affinity DataIC50:  52nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242361(US10047093, 8-18 | US10392392, Example 8-18 | US10...)
Affinity DataIC50:  53nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM50043663(CHEMBL3355551 | US10392392, Example 8-55 | US10875...)
Affinity DataIC50:  54nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242393(US10047093, 8-75 | US10392392, Example 8-75 | US10...)
Affinity DataIC50:  56nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
Sumitomo Dainippon Pharma Oncology

US Patent
LigandPNGBDBM242391(US10047093, 8-72 | US10392392, Example 8-72 | US10...)
Affinity DataIC50:  58nMAssay Description:One illustrative manner in which Pim-1 kinase activity can be determined is by quantifying the amount of ATP remaining in solution after an in vitro ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 120 total ) | Next | Last >>
Jump to: